Healthcare provider profile · identity verified

Mabel Rivera-Padilla, M.D.

Family Practice · JACKSONVILLE, FL · NPI 1215228267

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	573	208
Lisinopril	Lisinopril	391	128
Levothyroxine Sodium	Levothyroxine Sodium	379	127
Gabapentin	Gabapentin	332	143
Losartan Potassium	Losartan Potassium	324	123
Amlodipine Besylate	Amlodipine Besylate	251	103
Metoprolol Succinate	Metoprolol Succinate	225	85
Tramadol Hcl	Tramadol Hcl	220	62
Rosuvastatin Calcium	Rosuvastatin Calcium	211	82
Metformin Hcl	Metformin Hcl	182	72
Albuterol Sulfate Hfa	Albuterol Sulfate	179	75
Omeprazole	Omeprazole	162	63
Pantoprazole Sodium	Pantoprazole Sodium	159	67
Hydrochlorothiazide	Hydrochlorothiazide	155	61
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	152	40
Tamsulosin Hcl	Tamsulosin Hcl	151	59
Simvastatin	Simvastatin	148	59
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	147	71
Glipizide Er	Glipizide	144	50
Famotidine	Famotidine	114	51
Acetaminophen-Codeine	Acetaminophen With Codeine	112	54
Tizanidine Hcl	Tizanidine Hcl	108	61
Trazodone Hcl	Trazodone Hcl	104	45
Furosemide	Furosemide	102	49
Duloxetine Hcl	Duloxetine Hcl	91	36
Prednisone	Prednisone	87	75
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	82	72
Pioglitazone Hcl	Pioglitazone Hcl	81	32
Fluticasone Propionate	Fluticasone Propionate	80	45
Pravastatin Sodium	Pravastatin Sodium	80	26
Eliquis	Apixaban	77	25
Clopidogrel	Clopidogrel Bisulfate	74	32
Montelukast Sodium	Montelukast Sodium	73	31
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	71	30
Sertraline Hcl	Sertraline Hcl	70	32
Vitamin D2	Ergocalciferol (Vitamin D2)	69	29
Alendronate Sodium	Alendronate Sodium	63	27
Azithromycin	Azithromycin	63	59
Pregabalin	Pregabalin	63	15
Finasteride	Finasteride	60	22
Meloxicam	Meloxicam	60	32
Alprazolam	Alprazolam	59	18
Clonazepam	Clonazepam	59	19
Trulicity	Dulaglutide	59	17
Celecoxib	Celecoxib	58	33
Ciprofloxacin Hcl	Ciprofloxacin Hcl	58	51
Methylprednisolone	Methylprednisolone	58	54
Metoprolol Tartrate	Metoprolol Tartrate	58	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	18
Carvedilol	Carvedilol	56	21
Hydralazine Hcl	Hydralazine Hcl	55	19
Diclofenac Potassium	Diclofenac Potassium	53	37
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	18
Ozempic	Semaglutide	47	14
Glipizide	Glipizide	46	17
Jardiance	Empagliflozin	45	21
Nifedipine Er	Nifedipine	44	16
Xarelto	Rivaroxaban	43	19
Potassium Chloride	Potassium Chloride	42	21
Telmisartan	Telmisartan	41	21
Escitalopram Oxalate	Escitalopram Oxalate	39	17
Januvia	Sitagliptin Phosphate	38	13
Allopurinol	Allopurinol	37	14
Lantus	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Sucralfate	Sucralfate	37	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	15
Venlafaxine Hcl Er	Venlafaxine Hcl	37	18
Spironolactone	Spironolactone	36	15
Citalopram Hbr	Citalopram Hydrobromide	35	17
Lovastatin	Lovastatin	35	suppressed
Buspirone Hcl	Buspirone Hcl	34	13
Naproxen	Naproxen	34	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	27
Ezetimibe	Ezetimibe	31	suppressed
Solifenacin Succinate	Solifenacin Succinate	30	suppressed
Metformin Hcl Er	Metformin Hcl	29	16
Myrbetriq	Mirabegron	28	11
Donepezil Hcl	Donepezil Hcl	27	13
Bupropion Xl	Bupropion Hcl	26	11
Temazepam	Temazepam	26	suppressed
Valsartan	Valsartan	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	12
Baclofen	Baclofen	22	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	22	19
Lorazepam	Lorazepam	22	suppressed
Ibuprofen	Ibuprofen	21	12
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	20	15
Levofloxacin	Levofloxacin	20	20
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	18
Brilinta	Ticagrelor	19	suppressed
Constulose	Lactulose	19	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Atenolol	Atenolol	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	12
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Cephalexin	Cephalexin	17	16
Memantine Hcl	Memantine Hcl	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	17
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Nystatin	Nystatin	16	13
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Moxifloxacin Hcl	Moxifloxacin Hcl	15	15
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Clotrimazole	Clotrimazole	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	14	14
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Glimepiride	Glimepiride	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Torsemide	Torsemide	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error